Molecular Carcinogenesis

Papers
(The H4-Index of Molecular Carcinogenesis is 20. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-04-01 to 2025-04-01.)
ArticleCitations
Corrigendum57
RETRACTION: “LncAPC Drives Wnt/Β‐Catenin Activation and Liver TIC Self‐Renewal Through EZH2 Mediated APC Transcriptional Inhibition”34
A novel oncogene trigger transposable element derived‐1 promotes oral squamous cell carcinoma progression via evoking immune inhibition29
USP9X deubiquitinates and stabilizes CDC123 to promote breast carcinogenesis through regulating cell cycle28
The Role of HADHB in Mitochondrial Fatty Acid Metabolism During Initiation of Metastasis in ccRCC28
Guangsangon E triggers mitochondria dysfunction and mitophagy in triple‐negative breast cancer and leads to non‐apoptotic cell death28
Issue Information ‐ Ed Board27
The FOXO1/G6PC axis promotes gastric cancer progression and mediates 5‐fluorouracil resistance by targeting the PI3K/AKT/mTOR signaling pathway26
26
Issue Information ‐ Ed Board25
24
24
Hsa_circ_0088036 promotes nonsmall cell lung cancer progression by regulating miR‐1343‐3p/Bcl‐3 axis through TGFβ/Smad3/EMT signaling24
Issue Information ‐ Ed Board23
HNRNPC promotes estrogen receptor‐positive breast cancer cell cycle by stabilizing WDR77 mRNA in an m6A‐dependent manner23
Setting up clinical trials for success: Applying preclinical advances in combined TGFβ/PD‐L1 inhibition to ongoing clinical studies23
YAP‐LAMB3 axis dictates cellular resistance of pancreatic ductal adenocarcinoma cells to gemcitabine22
UBE2D1 promotes glioblastoma proliferation by modulating p21 ubiquitination21
ATP citrate lyase promotes the progression of hepatocellular carcinoma by activating the REGγ‐proteasome pathway21
TMED3 stabilizes SMAD2 by counteracting NEDD4‐mediated ubiquitination to promote ovarian cancer20
20
0.11307311058044